Invesco Ltd. Raises Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Invesco Ltd. lifted its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 30.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 162,146 shares of the company’s stock after purchasing an additional 37,718 shares during the quarter. Invesco Ltd.’s holdings in LifeStance Health Group were worth $1,195,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Wells Fargo & Company MN lifted its position in LifeStance Health Group by 36.2% during the fourth quarter. Wells Fargo & Company MN now owns 74,731 shares of the company’s stock worth $551,000 after buying an additional 19,869 shares during the period. Trexquant Investment LP boosted its position in shares of LifeStance Health Group by 111.6% in the fourth quarter. Trexquant Investment LP now owns 692,037 shares of the company’s stock worth $5,100,000 after acquiring an additional 364,990 shares during the last quarter. Geode Capital Management LLC grew its holdings in LifeStance Health Group by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company’s stock valued at $25,546,000 after purchasing an additional 13,293 shares during the period. Wellington Management Group LLP increased its position in LifeStance Health Group by 9.2% during the fourth quarter. Wellington Management Group LLP now owns 5,276,237 shares of the company’s stock worth $38,886,000 after purchasing an additional 445,796 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in LifeStance Health Group by 507.8% during the fourth quarter. JPMorgan Chase & Co. now owns 575,154 shares of the company’s stock worth $4,239,000 after purchasing an additional 480,518 shares during the period. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Insider Buying and Selling

In other news, insider Lisa K. Miller sold 18,845 shares of the firm’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the completion of the sale, the insider now directly owns 339,810 shares in the company, valued at $2,344,689. This trade represents a 5.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 6.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages have recently issued reports on LFST. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. KeyCorp assumed coverage on LifeStance Health Group in a research note on Tuesday, April 8th. They issued an “overweight” rating and a $9.00 price objective on the stock. Finally, Canaccord Genuity Group initiated coverage on shares of LifeStance Health Group in a research report on Thursday, April 3rd. They set a “buy” rating and a $8.00 target price for the company. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, three have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $8.30.

LifeStance Health Group Trading Down 0.8 %

LFST opened at $6.52 on Friday. The firm has a market capitalization of $2.54 billion, a P/E ratio of -25.08 and a beta of 1.30. The firm’s 50 day moving average is $6.89 and its 200-day moving average is $7.29. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 52-week low of $4.64 and a 52-week high of $8.61.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.